APA (7th ed.) Citation

S, C., L, X., P, G., CB, E., M, C., M, C., . . . I, K. (2024). Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: A 3-year follow-up longitudinal study. Molecular psychiatry, 29(11), 3669. https://doi.org/10.1038/s41380-024-02631-4

Chicago Style (17th ed.) Citation

S, Camporesi, et al. "Neurocognition and NMDAR Co-agonists Pathways in Individuals with Treatment Resistant First-episode Psychosis: A 3-year Follow-up Longitudinal Study." Molecular Psychiatry 29, no. 11 (2024): 3669. https://doi.org/10.1038/s41380-024-02631-4.

MLA (9th ed.) Citation

S, Camporesi, et al. "Neurocognition and NMDAR Co-agonists Pathways in Individuals with Treatment Resistant First-episode Psychosis: A 3-year Follow-up Longitudinal Study." Molecular Psychiatry, vol. 29, no. 11, 2024, p. 3669, https://doi.org/10.1038/s41380-024-02631-4.